Performance of a fully automated sirolimus assay on the dade behring dimension® clinical chemistry system

被引：0
|
作者：
Wei, Tie Q. [1 ]
Posey, Amy C. [1 ]
Schaible, Christy A. [1 ]
Zheng, Yifeng [1 ]
Yang, Yali [1 ]
Duffy, James E. [1 ]
机构：
[1] Dade Behring Inc, Newark, DE 19714 USA
来源：
THERAPEUTIC DRUG MONITORING | 2007年 / 29卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
150
引用
收藏
页码：507 / 507
页数：1
相关论文
共 50 条
  • [41] Validation of revised iron Flex® reagent and calibrator on dade behring Dimension® clinical chemistry systems
    Wesenberg, J.
    Mannino, E.
    Anderson, D.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A35 - A35
  • [42] Evaluation of the lipase assay on the Beckman Coulter SYNCHRON LXi System and comparison to the DADE BEHRING Dimension System
    Borge, P. D.
    Boardman, D.
    Uthup, M.
    Jin, M.
    CLINICAL CHEMISTRY, 2006, 52 (06) : A157 - A157
  • [43] Evaluation of the Dade Behring Dimension RxL: integrated chemistry system-pediatric reference ranges
    Ghoshal, AK
    Soldin, SJ
    CLINICA CHIMICA ACTA, 2003, 331 (1-2) : 135 - 146
  • [44] Analytical performance of turbidimetric methods for complement C3 and C4 on the Dade Behring Dimension® clinical chemistry system.
    Pierson-Perry, JF
    Kaminski, D
    Larson, L
    Moran, C
    Wessel, B
    CLINICAL CHEMISTRY, 2000, 46 (06) : A145 - A145
  • [45] Development of a no-pretreatment immunoassay for CSA C2 monitoring on the Dade Behring Dimension® clinical chemistry system
    Wei, T
    Bantum, L
    Bolle, G
    THERAPEUTIC DRUG MONITORING, 2005, 27 (02) : 212 - 212
  • [46] Interference testing of HBOC-201, an oxygen based therapeutic, with Dade Behring chemistry assays performed on the Dimension® clinical chemistry system
    Rea, DM
    Posey, A
    Caffo, AL
    CLINICAL CHEMISTRY, 2005, 51 : A49 - A50
  • [47] Performance characteristics of a no-pretreatment, random access sirolimus assay for the Dimension® RxL clinical chemistry system
    Cervinski, Mark A.
    Duh, Show-Hong
    Hock, Karl G.
    Gray, Jeffery
    Wei, Tie Q.
    Kilgore, Daniel C.
    Christenson, Robert H.
    Scott, Mitchell G.
    CLINICAL BIOCHEMISTRY, 2009, 42 (10-11) : 1123 - 1127
  • [48] Evaluation of a new lithium colorimetric assay performed on the Dade Behring Dimension® X-pand™ system
    Gruson, D
    Lallali, A
    Furlan, V
    Taburet, AM
    Legrand, A
    Conti, M
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (09) : 1066 - 1068
  • [49] Performance characteristics for an alternative range of clinical reagents for Dade-Behring DIMENSION Clinical Systems.
    Fitzgerald, SP
    Piper, K
    Campbell, JJ
    King, M
    Lamont, JV
    CLINICAL CHEMISTRY, 2000, 46 (06) : A28 - A28
  • [50] Resolution of false elevations in the Dade Behring Dimension® RxL PSA assay.
    Sokoll, LJ
    Mohr, P
    Wallerson, G
    Chan, DW
    CLINICAL CHEMISTRY, 2001, 47 (06) : A139 - A139
12345